Skip to content

Deprescribing in a Long Term Care Facility

Impact of a Deprescribing Intervention on Nursing Home Residents: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03091153
Enrollment
67
Registered
2017-03-27
Start date
2017-03-30
Completion date
2019-06-01
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polypharmacy

Brief summary

This study will develop, implement and evaluate a deprescribing initiative at a Canadian Long Term Care (LTC) Facility. Residents currently undergo an annual medication review as part of the clinical pharmacy services provided in the LTC facility. For this study, eligible residents will be randomized to receive either a deprescribing focused medication review or usual care. The deprescribing focused medication therapy assessments will be done on half of the 143 residents residing on the second and third floors of the facility. The other half of residents will serve as the control group and continue to receive their annual medication review and regular care from the attending physicians and nurses. The deprescribing intervention will be delivered by final year pharmacy students completing their practice experiences, under the supervision of clinical pharmacists at the LTC facility and clinical pharmacists from Memorial University's Medication Therapy Services (MTS) Clinic. Currently the clinic has a well developed procedure for providing in depth medication therapy reviews for residents of the community, upon referral by their primary care physician. Students will adapt this model of medication review to have a stronger deprescribing focus and be applicable to elderly residents of a LTC facility. The intervention will consist of an in depth medication therapy review with a focus on identifying any medications that may no longer be required or are deemed to be inappropriate or potentially unsafe in the elderly based on currently guidelines/criteria. The students will work closely with members of the resident's care team on a daily basis, as well as the resident and their family, to develop and implement a deprescribing plan.

Interventions

OTHERMedication Review

In depth medication review with a focus on deprescribing

Sponsors

Eastern Health
CollaboratorOTHER
Memorial University of Newfoundland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(all of the following): 1. Over 65 years of age 2. Reside in St. Patrick's Mercy Home (2nd or 3rd floor units)

Exclusion criteria

(any of the following): 1. Do not take any regularly scheduled medications 2. Are receiving palliative care 3. Resident's physician or nursing team do not support participation 4. Resident or their substitute decision maker decline participation

Design outcomes

Primary

MeasureTime frameDescription
Change in number of medications taken daily by residents3 and 6 months after receiving interventionMeasured using facility medication logs and patient health records

Secondary

MeasureTime frameDescription
All cause mortality rate3 and 6 months after receiving the interventionMeasured using patient health records
Instance of falls in the last 30 days3 and 6 months after receiving the interventionMeasured using facility fall report logs
Cognitive function score3 and 6 months after receiving the interventionMeasured using Cognitive Performance Scale (CPS) obtained from Resident Assessment Instrument (RAI) MDS 2.0
Bowel functionbaseline, 3 and 6 months after receiving the interventionMeasured using bowel chart data for the 14 days prior to the assessment date
Frequency of emergency room visits, unplanned hospital admission and/or unplanned GP visits3 and 6 months after receiving the interventionMeasured using patient health records
Changes in general health3 and 6 months after receiving the interventionMeasured using the Changes in Health, End-Stage Disease and Signs and Symptoms (CHESS) Score obtained from RAI MDS 2.0
Frequency of pain3 and 6 months after receiving the interventionMeasured using the Pain Scale obtained from RAI MDS 2.0
Social engagement3 and 6 months after receiving the interventionMeasured using Index of Social Engagement (ISE) Score obtained from RAI MDS 2.0
Aggressive behaviour3 and 6 months after receiving the interventionMeasured using the Aggressive Behaviour Scale (ABS) obtained from RAI MDS 2.0
Independence in activities of daily living3 and 6 months after receiving the interventionMeasured using the Activities of Daily Living Scale (ADL) obtained from RAI MDS 2.0

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026